149 related articles for article (PubMed ID: 34041309)
21. Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.
Rea K; Ford GK; Olango WM; Harhen B; Roche M; Finn DP
Eur J Neurosci; 2014 Feb; 39(3):435-43. PubMed ID: 24494683
[TBL] [Abstract][Full Text] [Related]
22. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
[TBL] [Abstract][Full Text] [Related]
23. Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus.
Chiu CQ; Castillo PE
Neuropharmacology; 2008 Jan; 54(1):68-78. PubMed ID: 17706254
[TBL] [Abstract][Full Text] [Related]
24. Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury.
Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
J Pharmacol Exp Ther; 2005 Apr; 313(1):88-94. PubMed ID: 15626718
[TBL] [Abstract][Full Text] [Related]
25. Lack of presynaptic interaction between glucocorticoid and CB1 cannabinoid receptors in GABA- and glutamatergic terminals in the frontal cortex of laboratory rodents.
Bitencourt RM; Alpár A; Cinquina V; Ferreira SG; Pinheiro BS; Lemos C; Ledent C; Takahashi RN; Sialana FJ; Lubec G; Cunha RA; Harkany T; Köfalvi A
Neurochem Int; 2015 Nov; 90():72-84. PubMed ID: 26196379
[TBL] [Abstract][Full Text] [Related]
26. Endocannabinoid CB1 receptor-mediated rises in Ca(2+) and depolarization-induced suppression of inhibition within the laterodorsal tegmental nucleus.
Soni N; Kohlmeier KA
Brain Struct Funct; 2016 Apr; 221(3):1255-77. PubMed ID: 25573246
[TBL] [Abstract][Full Text] [Related]
27. Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection.
Nasehi M; Rostam-Nezhad E; Ebrahimi-Ghiri M; Zarrindast MR
Behav Brain Res; 2017 Jan; 317():272-278. PubMed ID: 27686024
[TBL] [Abstract][Full Text] [Related]
28. Group I metabotropic glutamate receptors inhibit GABA release at interneuron-Purkinje cell synapses through endocannabinoid production.
Galante M; Diana MA
J Neurosci; 2004 May; 24(20):4865-74. PubMed ID: 15152047
[TBL] [Abstract][Full Text] [Related]
29. Type-1 cannabinoid receptor signaling in neuronal development.
Gaffuri AL; Ladarre D; Lenkei Z
Pharmacology; 2012; 90(1-2):19-39. PubMed ID: 22776780
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus.
Guggenhuber S; Alpar A; Chen R; Schmitz N; Wickert M; Mattheus T; Harasta AE; Purrio M; Kaiser N; Elphick MR; Monory K; Kilb W; Luhmann HJ; Harkany T; Lutz B; Klugmann M
Brain Struct Funct; 2016 May; 221(4):2061-74. PubMed ID: 25772509
[TBL] [Abstract][Full Text] [Related]
31. Long-term depression of presynaptic cannabinoid receptor function at parallel fibre synapses.
Yang Y; Kreko-Pierce T; Howell R; Pugh JR
J Physiol; 2019 Jun; 597(12):3167-3181. PubMed ID: 31020998
[TBL] [Abstract][Full Text] [Related]
32. Presynaptic mGluRs Control the Duration of Endocannabinoid-Mediated DSI.
Colmers PLW; Bains JS
J Neurosci; 2018 Dec; 38(49):10444-10453. PubMed ID: 30355625
[TBL] [Abstract][Full Text] [Related]
33. Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.
André VM; Cepeda C; Cummings DM; Jocoy EL; Fisher YE; William Yang X; Levine MS
Eur J Neurosci; 2010 Jan; 31(1):14-28. PubMed ID: 20092552
[TBL] [Abstract][Full Text] [Related]
34. Interaction of basolateral amygdala, ventral hippocampus and medial prefrontal cortex regulates the consolidation and extinction of social fear.
Qi CC; Wang QJ; Ma XZ; Chen HC; Gao LP; Yin J; Jing YH
Behav Brain Funct; 2018 Mar; 14(1):7. PubMed ID: 29554926
[TBL] [Abstract][Full Text] [Related]
35. Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina.
Papadogkonaki S; Theodorakis Κ; Thermos K
Exp Eye Res; 2019 Aug; 185():107694. PubMed ID: 31199905
[TBL] [Abstract][Full Text] [Related]
36. Disruption of peri-adolescent endocannabinoid signaling modulates adult neuroendocrine and behavioral responses to stress in male rats.
Lee TT; Hill MN; Hillard CJ; Gorzalka BB
Neuropharmacology; 2015 Dec; 99():89-97. PubMed ID: 26192544
[TBL] [Abstract][Full Text] [Related]
37. Putative Activation of Cannabinoid Receptor Type 1 Prevents Brain Oxidative Stress and Inhibits Aggressive-Like Behavior in Zebrafish.
Pinheiro EF; Cardoso PB; Luz WL; Assad N; Santos-Silva M; Leão LKR; de Moraes SAS; Passos ADC; de Jesus Oliveira Batista E; Oliveira KRHM; Gouveia A; Herculano AM
Cannabis Cannabinoid Res; 2024 Feb; 9(1):65-73. PubMed ID: 36576997
[No Abstract] [Full Text] [Related]
38. Exposure to cannabinoid agonist WIN 55,212-2 during early adolescence increases alcohol preference and anxiety in CD1 mice.
Frontera JL; Gonzalez Pini VM; Messore FL; Brusco A
Neuropharmacology; 2018 Jul; 137():268-274. PubMed ID: 29778010
[TBL] [Abstract][Full Text] [Related]
39. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis.
Patel S; Roelke CT; Rademacher DJ; Cullinan WE; Hillard CJ
Endocrinology; 2004 Dec; 145(12):5431-8. PubMed ID: 15331569
[TBL] [Abstract][Full Text] [Related]
40. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
